Open AccessEffect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda
Author(s) -
Ned Sacktor,
Deanna Saylor,
Gertrude Nakigozi,
Noeline Nakasujja,
Kevin Robertson,
M. Kate Grabowski,
Alice Kisakye,
James Batte,
Richard Mayanja,
Aggrey Anok,
Ronald H. Gray,
Maria J. Wawer
Publication year - 2019
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000001992
Subject(s) - neurocognitive , medicine , depression (economics) , cohort , antiretroviral therapy , human immunodeficiency virus (hiv) , dementia , viral load , stage (stratigraphy) , neuropsychology , cohort study , pediatrics , immunology , psychiatry , cognition , disease , biology , paleontology , economics , macroeconomics
Combination antiretroviral therapy (ART) improves HIV-associated neurocognitive disorder (HAND) stage in the United States where subtype B predominates, but the effect of ART and subtype on HAND stage in individuals in Uganda with subtypes D and A is largely unknown.